Study of Dasatinib, Androgen Deprivation Therapy and Radiation

Summary

Radiation and androgen deprivation is a common modality for patients with localized prostate cancer. Unfortunately for patients with intermediate to high risk prostate cancer incomplete tumor eradication and subsequent relapse occurs in 50-75% of patients. The Src pathway appears to be integral to the pathobiology of prostate cancer and may be fundamental to radioresistance.

Timeline

Start

2013-01

Primary completion

2013-04

Completion

2013-04

Drugs

Indications